The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 242.00
Bid: 241.00
Ask: 241.50
Change: 3.00 (1.26%)
Spread: 0.50 (0.207%)
Open: 239.00
High: 242.00
Low: 238.00
Prev. Close: 239.00
AGT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Factsheet

7 Jul 2023 16:39

RNS Number : 3976F
AVI Global Trust PLC
07 July 2023
 

 

AVI GLOBAL TRUST PLC

 

Monthly Update

 

AVI Global Trust plc (the "Company") presents its Update, reporting performance figures for the month ended 30 June 2023.

 

This Monthly Newsletter is available on the Company's website at:

https://www.assetvalueinvestors.com/content/uploads/2023/07/AGT-JUNE-2023.pdf

 

 

Performance Total Return

 

This investment management report relates to performance figures to 31 May 2023.

 

Total Return (£)

Month

Calendar Yr

to date

1Y

3Y

5Y

10Y

AGT NAV

0.5%

2.0%

7.1%

44.9%

40.1%

131.9%

MSCI ACWI Ex US

1.9%

3.6%

7.7%

19.8%

23.4%

89.7%

MSCI ACWI

3.1%

7.8%

11.3%

32.9%

53.3%

176.1%

 

 

Manager's Comment

 

AVI Global Trust (AGT)'s NAV increased by +0.5% in June.

 

The hedged position in Brookfield Corporation (+12%), Apollo (+15%), FEMSA (+10%) and KKR (+6%) were the largest positive contributors. Schibsted (-11%), Wacom (-16%) and Oakley Capital (-6%) were the most meaningful detractors.

 

D'Ieteren

 

Over the last few months, we have been adding to our position in D'Ieteren on share price weakness, such that the company is now a 4.2% weight in the portfolio.

 

Since reporting what we considered to be a strong set of full year results in early March the shares have declined -13%, underperforming the MSCI Europe by -11%. Whilst operating profit for D'Ieteren's underlying assets "beat" consensus expectations, investors were perturbed by significant working capital build-up and correspondingly low free cash flow generation. We believe such fears are undue, with the key culprit being D'Ieteren Autos (9% of NAV), where free cash flow swung from €108m to negative €101m as VW accelerated deliveries during the last two weeks of the quarter. This led to a €155m working capital outflow - or as management described it on the earnings call "a photo finish that was not very pleasant". This is a heavy-handed tactic we have seen from VW before (e.g. 2018), but one that normalises over time.

 

In our December newsletter we focused on D'Ieteren's key asset, Belron, which accounts for 63% of NAV following its payment of a €1.1bn dividend earlier this year. As discussed then, Belron has considerable scale advantages and benefits from the long-term growth trend of the proliferation of Advanced Driver Assistance System ("ADAS") cameras and increased windshield complexity.

 

Whilst Belron will remain the key asset in terms of NAV growth and investment case, we are increasingly encouraged by D'Ieteren's newer smaller assets, namely TVH Parts (TVH) and Parts Holding Europe (PHE). We believe the successful operation of these assets has the potential to boost management credibility and alleviate investors' concerns about re-investment risk / capital allocation, thereby reducing the wide discount at which the shares trade.

 

Although TVH is the larger and higher quality of the two assets, we believe the 2022 acquisition of PHE - a predominantly French automotive spare parts distributor - appears to be a particularly astute one, with D'Ieteren acquiring the business from Bain following a failed IPO.

 

Automotive spare parts flow from manufacturers, through distributors to retail and service centres and eventually end customers (drivers). The spare part aftermarket is divided between the Original Equipment Manufacturers (OEM) aftermarket and Independent Aftermarket (IAM), in which PHE operate. In the OEM aftermarket, automakers sell premium-priced branded parts, most typically for newer generation in warranty models, which are principally distributed through their dealer networks. The IAM on the other hand, operates independently of automakers and is much broader, covering cars typically aged >5 years old, with the average car served by PHE circa 13 years old.

 

Unlike the auto industry at large, demand for spare parts is highly defensive and stable with the bulk of sales non-discretionary in nature. Moreover, there is an element of counter-cyclicality, in so far as customers are more likely to "make do" and repair during times of economic hardship. Within this the IAM is in turn even more predictable, as the stock and flow of the existing car parc and its resultant demand can be modelled out for many years to come: 100% of the vehicles PHE expects to service in 2025, and ~50% of those in 2030, are already on the road.

 

In distribution businesses (relative) scale is a key determinant of success. PHE are a top three customer to most large suppliers, resulting in considerable purchasing economies of scale compared with smaller operators.

 

In distribution businesses (relative) scale is a key determinant of success. PHE are a top three customer to most large suppliers, resulting in considerable purchasing economies of scale compared with smaller operators. Scale also creates distribution centre density and allows for automation of complex logistics processes, both of which support best in class delivery times, with 90% of SKUs deliverable in two hours and some customers receiving up to six deliveries per day. Combined with inventory breadth, this gives PHE an unmatched ability to have the right part in the right place at the right time. In turn this translates to >40% gross margins, which drop down to high single digit operating margins.

 

Sales have grown at c.6% p.a. since 2010, although a decent chunk of this has been in-organic as PHE have rolled up many small operators. The market remains highly fragmented, particularly compared to the US, and we expect PHE to continue to pursue a consolidation strategy, with considerable synergies as acquirees are plugged into PHE's procurement systems. In the main these will likely be funded through internal cash flows, but over time there could be opportunities for D'Ieteren to deploy more meaningful amounts of capital.

 

D'Ieteren's acquisition of PHE came at an enterprise value of €1.7bn and an initial equity outlay of €571m. This equated to a trailing EV/EBITDA multiple of 7x and ~11x free cash flow. This represents a significant discount to listed peers, as well as M&A transactions, with GPC and LKQ having paid 10-11x EBITDA for Alliance and Rhiag in recent years. To complete the deal the EU mandated the disposal of PHE's windscreen repairs activities for just over €100m. As such the net equity outlay for PHE equates to less than 5x this coming year's profit before tax. We believe this represents a steal and should, combined with the acquisition of TVH, help ameliorate some of the market's concern surrounding re-investment risk (which became a valid criticism for the company following its ill-fated, and now immaterial, acquisition of Moleskine in 2014).

 

Returning to D'Ieteren, the decline in the shares combined with NAV growth means the company now trades at an 42% discount to our estimated NAV. Belron, TVH and PHE collectively account for 79% of NAV and exhibit largely non-discretionary demand drivers; combined with the prospect for margin expansion at Belron and accretive bolt on acquisitions at TVH and PHE we believe the prospects for NAV growth are attractive, with potential further upside from discount narrowing. Given the presence of private equity co-ownership at Belron we believe some form of corporate event is probable in the coming years, with management highly incentivised to increase the equity value, which should act as a catalyst for D'Ieteren shares.

WACOM

Wacom detracted 65ps from performance, with a -16% share price return that was especially painful in a buoyant market. It's hard to link the share price weakness to a specific event, with all the weakness coming in June after the full-year results announcement in the middle of May. We suspect the weakness was driven by selling pressure from one of Wacom's largest shareholders who announced a reduction in their stake.

 

Although management are listening to our suggestions and have committed to a buyback program for up to 20% of their shares, the operating environment has weighed heavily on profits. Despite sales growing +4% last year, cost inflation dragged gross profits -21% lower, while SG&A investments led to a -85% fall in operating profits. The weakness came entirely from the consumer business which saw a swing in operating profit from Y8.7bn to a -Y4.0bn loss this year.

 

Operating profits are expected to rebound +124% next year and recover to the FY03/22 levels in around three years. The pace of recovery is being hindered by Wacom's continued investment in future growth to which we are not necessarily opposed.

 

The difficult operating environment has already been reflected in the share price, and we still believe that Wacom has a technological advantage which will bear fruit as the digital writing market grows. We will continue engaging with management to enhance Wacom's corporate value and seek ways to recover the share price weakness.

 

 

Contributors / Detractors (in GBP)

 

Largest Contributors

1- month contribution

bps

% Weight

Long Brookfield Corp/Short Listed Underlyings

66

5.5

Apollo Global

53

5.0

FEMSA

44

6.4

KKR

35

6.2

IAC

31

3.5

 

Largest Detractors

1- month contribution

bps

% Weight

Schibsted ASA 'B'

-75

6.8

Wacom

-65

2.4

Oakley Capital Investments

-48

7.9

Pantheon International

-27

4.1

Symphony International Holdings

-19

2.8

 

 

Link Company Matters Limited

Corporate Secretary

 

07 July 2023

 

LEI: 213800QUODCLWWRVI968

 

The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the Newsletter referred to above, is neither incorporated into nor forms part of the above announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCUPUQWMUPWGAM
Date   Source Headline
3rd May 20242:08 pmRNSNet Asset Value(s)
2nd May 20245:43 pmRNSTransaction in Own Shares
2nd May 20241:55 pmRNSNet Asset Value(s)
1st May 20241:39 pmRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 202412:30 pmRNSNet Asset Value(s)
29th Apr 20241:34 pmRNSNet Asset Value(s)
26th Apr 202412:06 pmRNSNet Asset Value(s)
25th Apr 20241:57 pmRNSNet Asset Value(s)
24th Apr 202412:34 pmRNSNet Asset Value(s)
23rd Apr 20241:00 pmRNSNet Asset Value(s)
22nd Apr 202412:54 pmRNSNet Asset Value(s)
19th Apr 20245:35 pmRNSTransaction in Own Shares
19th Apr 20243:39 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
18th Apr 20245:40 pmRNSTransaction in Own Shares
18th Apr 202412:18 pmRNSNet Asset Value(s)
17th Apr 202412:24 pmRNSNet Asset Value(s)
16th Apr 202412:31 pmRNSNet Asset Value(s)
15th Apr 202412:44 pmRNSNet Asset Value(s)
12th Apr 20245:30 pmRNSTransaction in Own Shares
12th Apr 20242:09 pmRNSNet Asset Value(s)
11th Apr 20245:49 pmRNSTransaction in Own Shares
11th Apr 202412:59 pmRNSNet Asset Value(s)
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20241:01 pmRNSNet Asset Value(s)
9th Apr 20245:40 pmRNSTransaction in Own Shares
9th Apr 20243:48 pmRNSMonthly Factsheet
9th Apr 202412:20 pmRNSNet Asset Value(s)
9th Apr 202411:56 amRNSDirector/PDMR Shareholding
8th Apr 20244:58 pmRNSDirector/PDMR Shareholding
8th Apr 202412:58 pmRNSNet Asset Value(s)
8th Apr 202412:53 pmRNSAppointment of Corporate Broker
8th Apr 202412:39 pmRNSListing Rule 15.6.8
5th Apr 20241:57 pmRNSNet Asset Value(s)
4th Apr 20245:32 pmRNSTransaction in Own Shares
4th Apr 20241:13 pmRNSNet Asset Value(s)
3rd Apr 20245:32 pmRNSTransaction in Own Shares
3rd Apr 20242:28 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSKepler Trust Intelligence: New Research
2nd Apr 20245:30 pmRNSTransaction in Own Shares
2nd Apr 20244:32 pmRNSNet Asset Value(s)
2nd Apr 202412:31 pmRNSTotal Voting Rights
28th Mar 20245:32 pmRNSTransaction in Own Shares
28th Mar 20242:08 pmRNSNet Asset Value(s)
27th Mar 20245:48 pmRNSTransaction in Own Shares
27th Mar 20243:27 pmRNSNet Asset Value(s)
26th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20242:12 pmRNSNet Asset Value(s)
25th Mar 20245:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.